Efficacy of Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis with Severe Itch at Baseline and in Subgroups by Baseline Thresholds of Severe Itch: A Post Hoc Analysis of the JADE COMPARE and JADE DARE Clinical Trials